Thrive Partners Vii Growth Gp, Acquires 420,819 Shares of Oscar Health, Inc. (NYSE:OSCR) Stock

Oscar Health, Inc. (NYSE:OSCR) Director Thrive Partners Vii Growth Gp, acquired 420,819 shares of Oscar Health stock in a transaction dated Tuesday, November 12th. The shares were acquired at an average price of $13.68 per share, with a total value of $5,756,803.92. Following the completion of the transaction, the director now owns 5,452,081 shares of the company’s stock, valued at approximately $74,584,468.08. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Oscar Health Trading Down 0.6 %

OSCR stock traded down $0.08 during trading hours on Wednesday, hitting $13.48. 4,692,074 shares of the stock traded hands, compared to its average volume of 3,336,917. The company has a current ratio of 0.73, a quick ratio of 0.91 and a debt-to-equity ratio of 0.26. The stock has a 50-day simple moving average of $18.36 and a 200 day simple moving average of $18.33. Oscar Health, Inc. has a one year low of $6.93 and a one year high of $23.79.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same quarter last year, the business posted ($0.29) EPS. The business’s revenue for the quarter was up 68.3% on a year-over-year basis. On average, equities research analysts expect that Oscar Health, Inc. will post -0.01 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in OSCR. Vanguard Group Inc. lifted its stake in Oscar Health by 2.4% during the first quarter. Vanguard Group Inc. now owns 14,582,762 shares of the company’s stock valued at $216,846,000 after buying an additional 337,850 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of Oscar Health by 153.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock valued at $59,156,000 after acquiring an additional 2,409,160 shares in the last quarter. Renaissance Technologies LLC boosted its stake in Oscar Health by 31.7% in the 2nd quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock worth $61,478,000 after purchasing an additional 934,600 shares during the period. First Light Asset Management LLC grew its position in Oscar Health by 117.3% during the 1st quarter. First Light Asset Management LLC now owns 2,102,554 shares of the company’s stock worth $31,265,000 after purchasing an additional 1,134,919 shares in the last quarter. Finally, Assenagon Asset Management S.A. raised its stake in Oscar Health by 32.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock valued at $32,368,000 after purchasing an additional 507,009 shares during the period. Institutional investors and hedge funds own 75.70% of the company’s stock.

Analysts Set New Price Targets

OSCR has been the topic of several recent analyst reports. Bank of America downgraded Oscar Health from a “neutral” rating to an “underperform” rating and cut their target price for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. UBS Group assumed coverage on shares of Oscar Health in a research note on Monday, October 7th. They set a “neutral” rating and a $23.00 price objective on the stock. Finally, Piper Sandler reiterated an “overweight” rating and issued a $28.00 target price on shares of Oscar Health in a research report on Tuesday, September 10th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $22.93.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.